Report Overview:
Nonsteroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used for pain relief, stress reduction, and temperature control. These medications help alleviate symptoms such as period pain, sprains, strains, headaches, colds, flu, arthritis, and other long-term pain conditions. NSAIDs function by inhibiting COX-1 and COX-2 enzymes responsible for inflammation. Common examples of NSAIDs include aspirin, naproxen, ibuprofen, and paracetamol, which exhibit sedative and anti-inflammatory effects.
Market Value:
The global Oral Nonsteroidal Anti-Inflammatory Drugs market size was valued at USD 20,820 million in 2024. It is projected to grow significantly, reaching USD 31,710.68 million by 2032, with a Compound Annual Growth Rate (CAGR) of 5.40% during the forecast period.
In North America, the market was estimated at USD 5,938.93 million in 2024, with an anticipated CAGR of 4.63% from 2025 to 2032. This growth is fueled by increasing demand for effective pain management solutions and the rising prevalence of chronic conditions.
CAGR of 5.40% (2025 – 2032)
By Types:
• Penicillins
• Cephalosporins
• Tetracyclins
• Sulfonamides
By Applications:
Sterilization
Bacteriostasis
Key players include:
•Bayer AG
•Pfizer Inc
•Reckitt Benckiser Group PLC
•Novartis AG
•DAIICHI SANKYO COMPANY, LIMITED
•Zydus Group
•Lupin
•Including or Excluding key companies relevant to your analysis.
www.statsmarketresearch.com
